Vaccines should be obtained from multiple sources

ডেইলি স্টার সম্পাদকীয় প্রকাশিত: ২৬ এপ্রিল ২০২১, ০০:০০

The last thing that we wanted to hear now was that Bangladesh should not expect to get the Oxford-AstraZeneca vaccine from India anytime soon. Bangladesh is likely to run out of its stock of 10.2 million doses by the end of May. Clearly, Serum Institute of India (SII) has defaulted on its part of the agreement that it signed with the Bangladesh government, under which it was supposed to supply 5 million doses of Covid -19 vaccines every month. Not surprisingly, the supply of the vaccine has been disrupted due to a shortage of raw materials and India's internal demand.

সম্পূর্ণ আর্টিকেলটি পড়ুন

সংবাদ সূত্র


The Largest News Aggregator
in Bengali Language

Email: [email protected]

Follow us